Business
from24/7 Wall St.
2 months agoShare Offerings Prompt Huge Insider Buying in These 3 Biotechs
Large insider purchases, including Roivant’s nearly $350M Immunovant buy, indicate substantial insider confidence in several biotech and healthcare companies.